MEDICINE INTERACTION CHECKER

List of Medicines
Tablet Saaz-DS
Add medicines to view interactions
Found 10 interactions
Life-threatening (0)
Serious (10)
Moderate (0)
Minor (0)
Beneficial (0)

Tablet Saaz-DS & ATZ 50 Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

Tablet Saaz-DS & Azoran Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

Tablet Saaz-DS & Zesoris-AZ 50mg Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

Tablet Saaz-DS & Autorin 50mg Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

Tablet Saaz-DS & Vaprin Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

Tablet Saaz-DS & Azoalfa Tablet 50

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

Tablet Saaz-DS & Azanol Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

Tablet Saaz-DS & Azin Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

Tablet Saaz-DS & Imuzat 50mg Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

Tablet Saaz-DS & Azafly 50mg Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details